"Designing Growth Strategies is in our DNA"
In April 2017, NuGEN Technologies, Inc. launched Trio RNA-Seq, which is predominantly suited for low abundance transcripts applications. Transcriptomic is the study of the complete set of RNAs (transcriptome) encoded by the genome of an organism at a specific time or specific cell or under a specific set of conditions. Transcriptomics includes the consideration and assortment of transcriptomes and has diverse applications, including applications in molecular genetics.
Transcriptomics techniques include DNA microarrays and next-generation sequencing technologies called RNA-Seq. As the demand for transcriptomics is increasing, new players are entering into the market. For instance, in April 2017, Seven Bridges, a biomedical data analysis company announced a financial investment in Spatial Transcriptomics AB, a life science start-up, which is developing innovative technology to analyze tissue samples in two dimensions.
To gain extensive insights into the market, Request for Customization
Increasing demand for personalized medicines and rapid improvements in healthcare infrastructures are anticipated to fuel the growth of the drug discovery and research, which will eventually drive the growth of the global transcriptomic market during the forecast period. An increasing number of biopharmaceutical companies and rising expenditure on research and development is projected to boost the growth of the global transcriptomics market by 2026.
However, the lack of skilled professionals in emerging nations is expected to hamper the growth of the global transcriptomics market during the forecast period.
Some of the major companies operating in the global transcriptomics market are QIAGEN, Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, GE Healthcare Dharmacon Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Fluidigm Corporation, Promega Corporation, and others.
· Polymerase Chain Reaction (PCR)
· Next-Generation Sequencing (NGS)
· Drug Discovery
· Clinical Diagnostics
· Academic and Research Institutes
· Pharmaceutical Companies
· Biotechnology Companies
· North America (USA and Canada)
· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
· Latin America (Brazil, Mexico and Rest of Latin America)
· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)
Among the segmentation, pharmaceutical companies among end-user segment are projected to register comparatively higher share owing to increasing drug manufacturing.
Based on the region, the global transcriptomics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among the region, North America is expected to dominate the global transcriptomics market owing to increased demand for the personalized medicines, growing incidence of chronic disorders such as cancer and others, and high investment in the research and development of the transcriptomics technologies. Asia Pacific is expected to grow at a significant CAGR, during the forecast period due to the increasing number of pharmaceutical and biotechnology companies in the region, leading to higher demand for transcriptomics technologies, combined with increasing investments in R&D and drug development in the Asia Pacific.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm
“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”- UK-based Start-up in the Medical Devices Sector
“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”- One of the Largest Companies in the Defence Industry